Reproductive Health Care Intervention for Young Female Cancer Survivors

N/A

Recruiting

Led By H. Irene Su, MD, MSCE

Research Sponsored by University of California, San Diego

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Cancer diagnosis at Stages 0-IV

Be younger than 65 years old

Must not have

Women who are pregnant at recruitment

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 weeks after oncology visit

Awards & highlights

No Placebo-Only Group

Summary

"This trial aims to test if a program can help young female cancer survivors better engage in reproductive health care that aligns with their goals. The researchers believe that by implementing this program, more young cancer survivors

Who is the study for?

This trial is for young female cancer survivors living in Imperial County, California. They must have been diagnosed with cancer at any stage from 0-IV and be receiving care at a rural oncology clinic participating in the study. Participants need to speak English or Spanish but cannot join if they are pregnant.

What is being tested?

The study is testing a multi-component reproductive health care intervention aimed at improving engagement in reproductive health care that aligns with the goals of young female cancer survivors.

What are the potential side effects?

Since this trial focuses on a healthcare intervention rather than medication, traditional side effects like those seen with drugs may not apply. However, participants might experience emotional or psychological impacts related to discussions about fertility and reproductive health.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My cancer is at any stage from 0 to IV.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am currently pregnant.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 weeks after oncology visit

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 weeks after oncology visit

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks after oncology visit for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Proportion of patient's engagement in goal-concordant reproductive health care

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Multi-component interventionExperimental Treatment1 Intervention

After the intervention implementation, all cancer patients presenting to oncology clinical visits that meet eligibility criteria will receive the multi-component intervention.

0 / 2Eligibility criteria met